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E-mail address: j.hill@cphc.keele.ac.uk (J.C. Hill).Introduction: Clinicians require brief, practical tools to help identify low back pain (LBP) subgroups
requiring early, targeted secondary prevention. The STarT Back Tool (SBT) was recently validated to sub-
group LBP patients into early treatment pathways.
Aim: To test the SBT’s concurrent validity against an existing, popular LBP subgrouping tool, the Örebro
Musculoskeletal Pain Screening Questionnaire (ÖMPSQ), and to compare the clinical characteristics of
subgroups identiﬁed by each tool.
Methods: Two hundred and forty-four consecutive ‘non-speciﬁc’ LBP consulters at 8 UK GP practices aged
18–59 years were invited to complete a questionnaire. Measures included the ÖMPSQ and SBT, disability,
fear, catastrophising, pain intensity, episode duration and demographics. Instruments were compared
using Spearman’s correlations, tests for subgroup agreement and discriminant analysis of subgroup char-
acteristics according to reference standards.
Results: Completed SBT (9-items) and ÖMPSQ (24-items) data was available for 130/244 patients (53%).
The correlation of SBT and ÖMPSQ scores was ‘excellent (rs = 0.80). Subgroup characteristics were similar
across the low, medium and high subgroups, but, the proportions allocated to ‘low’, ‘medium’ and ‘high’
risk groups were different, with fewer patients in the SBT’s high risk group. Both instruments similarly
discriminated for reference standards such as disability, catastrophising, fear, comorbid pain and time
off work. The ÖMPSQ was better at discriminating pain intensity, while the SBT was better for discrim-
inating bothersomeness of back pain and referred leg pain.
Conclusions: The SBT baseline psychometrics performed similarly to the ÖMPSQ, but the SBT is shorter
and easier to score and is an appropriate alternative for identifying high risk LBP patients in primary care.
 2009 European Federation of International Association for the Study of Pain Chapters. Published by
Elsevier Ltd. All rights reserved.1. Introduction
Primary care evidence-based guidelines for non-speciﬁc back
pain highlight the importance of identifying indicators of poor
prognosis in order that treatment can be targeted appropriately
(Chou et al., 2007; van Tulder et al., 2006). Investigators increas-
ingly advocate that better identiﬁcation of potentially modiﬁable
prognostic indicators may lead to more effective early secondary
prevention of back pain in primary care (Boersma and Linton,
2005; Morley and Vlaeyen, 2005; Jellema et al., 2006; Koes et al.,
2006). Several back pain clinical tools exist to aid clinicians in iden-
tifying patients either ‘at risk’ of chronicity or to improve targeting
of treatment (Childs et al., 2004; Hicks et al., 2005; Dionne et al.,
2005; Truchon and Cote, 2005; Duijts et al., 2006; Neubauer
et al., 2006; Denison et al., 2007).ernational Association for the Stud
x: +44 01782 733911.The STarT Back Tool (SBT) is a recently validated tool developed
to identify subgroups of patients to guide the provision of early
secondary prevention in primary care (Hill et al., 2008). The con-
ceptual purposes of the SBT (Hill et al., 2008) were to identify pa-
tients with potentially treatment modiﬁable prognostic indicators
using a brief, user-friendly tool and to validate cut-off scores for
subgrouping patients into 1 of 3 a priori initial treatment options
in primary care (low, medium and high risk groups). The develop-
ment and validation of the STarT Back Tool (SBT) was recently re-
ported (Hill et al., 2008), but a head to head comparison with a
‘reference standard’ instrument was not evaluated. The Örebro
Musculoskeletal Pain Screening Questionnaire (ÖMPSQ: Linton
and Hallden, 1998) was considered the most appropriate ‘reference
standard’ against which to compare the SBT, as it is one of the most
widely used tools in clinical practice to similarly differentiate pri-
mary care back pain patients, and it has a common conceptual pur-
pose with the SBT of identifying high risk patients requiring
targeted treatment. As well as being a popular instrument, the
ÖMPSQ has been externally validated in numerous internationaly of Pain Chapters. Published by Elsevier Ltd. All rights reserved.
84 J.C. Hill et al. / European Journal of Pain 14 (2010) 83–89samples (Heneweer et al., 2007; Westman et al., 2008; Hough et al.,
2007; Margison and French, 2007; Nordeman et al., 2006; Jellema
et al., 2007; Gabel et al., 2008; Hurley et al., 2001; Grotle et al.,
2006; Linton and Boersma, 2003; Boersma and Linton, 2005;
Dunstan et al., 2005).
Clinicians wanting to follow evidence-based practice guidelines
to assess prognostic indicators for chronicity (Chou et al., 2007), re-
quire brief and practical tools to help them identify subgroups of
patients that may require early, targeted secondary prevention
pathways. The publication of the SBT (Hill et al., 2008) provides cli-
nicians with a choice, in addition to an existing ‘reference standard’
instrument, the ÖMPSQ. However, in order to decide which clinical
tool to use in practice, clinicians need to know how these instru-
ments compare, including the baseline clinical characteristics of
the subgroups identiﬁed by each tool.
The overall aim of this study was to therefore provide a head to
head comparison of the SBT’s concurrent validity against a best
available reference standard, the ÖMPSQ. Our objectives were to
test the correlation between the SBT and ÖMPSQ scores and agree-
ment of patients allocated to ‘low’, ‘medium’ and ‘high’ risk sub-
groups; and to compare the abilities of the SBT and ÖMPSQ
scales to discriminate patients according to validated reference
standard measures.1 In box and whisker plots the central line is the median, the box provides the
lower and upper quartiles, the whiskers are the 2.5% and 97.5% values, and extreme
values are noted with a ‘’ (Chambers et al., 1983).2. Methods
2.1. Properties of the ÖMPSQ and SBT
The ÖMPSQ consists of 24 self-report items (21 items are
scored), selected following a literature review to identify strong
independent risk factors for work absence. The authors deﬁned
‘poor prognosis’ as accumulated sick leave of 30 days or more at
six months follow up. The ÖMPSQ’s 21 scored items use an 11-
point response format, apart from item 1 (pain sites), which has
ﬁve descriptive components that are double weighted. The instru-
ment therefore provides a potential score ranging from two to 210
points. The reliability of the ÖMPSQ has been reported with a Kap-
pa of 0.83 (Linton and Hallden, 1998) and external validity, with a
number of different high risk cut-off scores, has been established in
a variety of patient populations and settings (Heneweer et al.,
2007; Westman et al., 2008; Hough et al., 2007; Margison and
French, 2007; Nordeman et al., 2006; Jellema et al., 2007; Gabel
et al., 2008; Hurley et al., 2001; Grotle et al., 2006; Linton and
Boersma, 2003; Boersma and Linton, 2005; Dunstan et al., 2005).
The predictive validity of the ÖMPSQ has also been investigated
in a number of studies, as summarised by Hockings et al. (2008).
Since the initial development of the ÖMPSQ, other authors have
used it to classify patients into low, medium and high ‘at risk’
groups (Nordeman et al., 2006).
The SBT has 9-items selected as predictive of ‘poor prognosis’
following a literature review and secondary analysis to identify
strong independent predictors for persistent disabling back pain.
The 9-items each use a dichotomised response format (‘agree’ or
‘disagree’), apart from one bothersomeness item, which uses a Lik-
ert scale. Overall SBT scores range from 0-9 and are produced by
summing all positive items; a psychosocial subscale score ranging
from 0 to 5 is produced by summing bothersomeness, fear, cata-
strophising, anxiety, and depression items (items 1, 4, 7, 8, and
9). The predictive validity and external validity of the STarT Back
Tool has been reported, as well as the SBT’s reliability, with a Kap-
pa of 0.79 (Hill et al., 2008).
Prognostic constructs included in both tools as single screening
items include disability, fear avoidance, anxiety, depression and
also an item on the patient’s perceived chance that ‘current pain
may become persistent’ or that the back pain is ‘never going toget any better’. Both instruments allocate ‘at risk’ patients based
on the presence or absence of known indicators of poor prognosis.
The SBT also discriminates patients using single items for bother-
someness, referred leg pain, and comorbid pain, while the ÖMPSQ
discriminates on the basis of additional items for pain intensity,
coping and work-related factors.
2.2. Data collection
Potential differences between the ÖMPSQ and SBT were ex-
plored using data from a cross-sectional survey of consecutive
adult patients (n = 131) who consulted their GP with low back
pain. The methods of patient recruitment have already been pub-
lished elsewhere (Hill et al., 2008). In brief, 244 participants were
invited to complete a questionnaire containing both the ÖMPSQ
and the SBT from 8 general practices in North Staffordshire and
Central Cheshire, UK using computerised Read Codes to identify re-
cent back pain consulters. This study received ethical approval
from the North Staffordshire Local Research Ethics Committee.
2.3. Analysis of data
The SBT and ÖMPSQ were scored according to the methods
speciﬁed by the instrument developers (Hill et al., 2008; Linton
and Hallden, 1998). Patients were classiﬁed into ‘low’, ‘medium’
and ‘high’ risk groups using derived cut-off scores for each instru-
ment. For the SBT, cut-offs recommended in the original article
were used (Hill et al., 2008); for the ÖMPSQ, we replicated the high
risk cut-off score determined within a UK primary care population
by Hurley et al. (2001) ofP112; and a cut-off of 90 to separate low,
from medium risk group patients, as used by Nordeman et al.
(2006). To score the ÖMPSQ among patients who were not work-
ers, (four work-related items are only relevant to those patients
in work), the procedure used by Jellema et al. (2007) was followed,
where the mean score of the remaining 17 items was imputed, on
the condition that at least 75% of all items were completed.
Correlations between the SBT and ÖMPSQ, and reference stan-
dard constructs included in both instruments: disability (Roland
and Morris Disability Questionnaire, RMDQ: Roland and Morris,
1983) fear avoidance (Tampa Scale of Kinesiaphobia, TSK: Kori
et al., 1990) and catastrophising (Pain Catastrophising Scale, PCS:
Sullivan et al., 1995) were calculated using Spearman’s rank corre-
lations. The magnitude of the reported correlation coefﬁcient was
evaluated with a correlation of 0.1–0.3 was small, >0.3–0.5 was
moderate, and greater than 0.5 was large (Cohen, 1998). In addi-
tion, box and whisker plot graphs were produced to visually pres-
ent the correlation between the SBT and ÖMPSQ.1
Observed agreement of the two tool’s allocation to ‘low’, ‘med-
ium’ and ‘high’ risk subgroupswas examinedby calculating absolute
agreement, and agreement beyond chance statistically evaluated
using a weighted Cohen’s kappa test. Kappa values were classiﬁed
for reference as follows: less than 0.00 showed poor agreement,
0.00–0.20, slight agreement; 0.21–0.40, fair agreement; 0.41–0.60,
moderate agreement; 0.61–0.80, substantial agreement; and great-
er than 0.80, near perfect agreement (Landis and Koch, 1977). The
McNemar Bowker test was used to determine whether disagree-
mentobservedwasevenlybalancedor signiﬁcantly skewed towards
the lower or higher group. The characteristics of patients selected for
‘low’, ‘medium’ and ‘high’ subgroups using the SBT andÖMPSQwere
compared using median scores for age, gender, episode duration,
bothersomeness, pain intensity, days off work, fear (TSK), cata-
strophising (PCS), ÖMPSQ scores and SBT scores (mean values were
J.C. Hill et al. / European Journal of Pain 14 (2010) 83–89 85used for age). TheMannWhitney test was used to test for statistical
differences between continuous data and the Chi-squared test used
for categorical data among thecharacteristics for discordant individ-
uals (patients for whom group allocation differed).
Finally, the ability of the two instruments’ total (and subscale)
scores to discriminate patients was compared by plotting receiver
operator characteristic (ROC) curves for various different reference
standard ‘cases’ (using the ‘case’ deﬁnitions provided in Table 3)
and calculating AUCs (95% CIs), with statistical differences tested210
SBT psychosoc
200
180
160
140
120
100
80
60
40
20
0
O
M
PS
Q
 to
ta
l s
co
re
43210
SBT to
200
180
160
140
120
100
80
60
40
20
0
O
M
PS
Q
 to
ta
l s
co
re
a
b
Fig. 1. Box plot graph of the ÖMPSQ total scores against (a) tusing the Wilcoxon statistic (Hanley and McNeil, 1982). Total
scores were entered as the ‘test’ variables and reference standard
‘cases’ as the ‘state’ variable.
3. Results
Complete data on the SBT and ÖMPSQwas available for 130/244
(53%) patients. The sample was 60% female, with a mean (±SD) age
of 44 (±10.0) and disability score (RMDQ) of 8.6 (±6.6). Back pain543
ial subscale score
98765
tal score
he SBT total score and (b) the SBT psychosocial subscale.
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6 months, and 48% >6 months, and 43% reported being ‘very’ or ‘ex-
tremely’ bothered by their back pain. The median scores (range) for
SBT and ÖMPSQwere 4.5 (0–9) and 98.8 (26.3–189.0), respectively.
The Spearman’s rank correlation coefﬁcients for the SBT total
scores and psychosocial subscale scores with the ÖMPSQ scores
were 0.802 and 0.769 respectively. The magnitude of the reported
correlation coefﬁcients was therefore, ‘large’ and was similar to the
correlation between disability (RMDQ) and the subgroup tools
(SBT = 0.813; ÖMPSQ = 0.830). Figures for fear (TSK) (SBT psycho-
logical subscale = 0.659; ÖMPSQ = 0.683) and catastrophising
(PCS) (SBT = 0.671; ÖMPSQ = 0.656) were lower but also classiﬁed
as ‘large’. Fig. 1 presents box plot graphs of the ÖMPSQ total score
against the SBT (a) total score and (b) psychosocial subscale and
demonstrate that increasing ÖMPSQ scores, correlated with higher
SBT scores across the full range of both instrument scales.
The proportions of patients allocated to ‘low’, ‘medium’ and
‘high’ risk groups by the SBT and ÖMPSQ were 40% cf 40%, 35% cf
22%, and 25% cf 38%, respectively. The ‘low’ risk proportion was
therefore the same, but the SBT allocated considerably fewer pa-
tients to the ‘high’ risk group, but signiﬁcantly more patients to
the ‘medium’ risk group than the ÖMPSQ (McNemar Bowker test
p = 0.022).
Observed agreement between the two instruments for alloca-
tion to ‘low’, ‘medium’ and ‘high’ risk groups, is presented in Table
1, with absolute agreement in 62% of patients. Weighted Cohen’s
kappa for agreement in allocation to the three subgroups beyond
chance was ‘moderate’, 0.57 (95% CI 0.47–0.68, p = 0.000). Agree-
ment about allocation to the ‘low’ risk group alone (‘low’ versus
‘medium’ or ‘high’) was ‘substantial’ at 0.63 (95% CIs 0.50–0.77,
p = 0.000).Table 1
Observed agreement of SBT and ÖMPSQ subgroups (n = 130).
ÖMPSQ subgroup SBT subgroup (n = 130)
Low Medium High
Low 41 11 0
Medium 10 13 6
High 2 20 27
Table 2
Medians [inter-quartile ranges] of clinical characteristics by low, medium and high subgr
Reference standard clinical characteristics Subgroup (n = 130)
Low
SBT ÖMPSQ
Age, median [IQR] 43 [33–52] 44 [34–56]
Female, number (%) 60 58
Episode duration category, median [IQR] 2 [1–4] 2 [1–4]
Bothersomeness, median [IQR] 2 [2–3] 2 2–3]
Pain intensity (NRS), median [IQR] 1.7 [0.7–3.3] 1.7 [0.7–3.0
Time off work in past 6/12 category, median [IQR] 2 [1–2] 2 [1–2]
Fear (TSK), median [IQR] 38 [34–42] 37 [33–39]
Catastrophising (PCS), median [IQR] 9 [5–17] 9 [5–13]
Disability (RMDQ), median [IQR] 2 [0–5] 2 [0–5]
ÖMPSQ total, median [IQR] 69 [47–87] 65 [47–79]
SBT total, median [IQR] 2 [0–3] 2 [0–3]
SBT Psych subscale, median [IQR] 0 [0–1] 0 [0–1]
TSK, Tampa Scale of Kinesiophobia; RMDQ, Roland-Morris Disability Questionnaire; NR
loskeletal Pain Screening Questionnaire; SBT, STarT Back Tool.
Episode duration categories: 1 = <1 month; 2 = 1–3-months; 3 = 4–6-months, 4 = 7 mont
Bothersomeness categories: 1 = not at all; 2 = slightly; 3 = moderately; 4 = very much; 5
Time off work categories: 1 = no time off, 2 = <1 week, 3 = 1–4 weeks, 4 = 1–3-months, 5
None of the above clinical characteristic differences between groups were statistically sig
for categorical data among discordant individuals (patients for whom group allocation dThe clinical characteristics of the subgroups (‘low’, ‘medium’
and ‘high’) derived using the SBT and ÖMPSQ are presented in Ta-
ble 2. The characteristics of the ‘low’ risk groups were almost iden-
tical (e.g. both had an RMDQ median of 2 and a pain NRS of 1.7).
The ‘medium’ risk groups differed only slightly with higher pain
and disability scores among those allocated by the SBT and the
‘high’ risk groups were also very similar although the ÖMPSQ ‘high’
risk group had slightly more females and had longer episode dura-
tions. However, these differences between the clinical characteris-
tics in the ‘medium’ and ‘high’ risk groups produced by both tools
were not statistically signiﬁcant (p > 0.05).
The ability of the two instruments’ total scores (and SBT sub-
scale scores) to discriminate patients deﬁned as ‘cases’ on refer-
ence standards is given in Fig. 2 and Table 3. There were no
signiﬁcant differences in the discriminative abilities of the SBT
and ÖMPSQ scales for ‘cases’ of disability, catastrophising, fear,
comorbid pain, time off work or episode duration reference stan-
dards. The SBT was signiﬁcantly better for discriminating bother-
some and referred leg pain ‘cases’ while the ÖMPSQ scores was
better at discriminating ‘cases’ of pain intensity.
4. Discussion
This study has provided a comparative analysis of the measure-
ment properties of the SBT and the ÖMPSQ for patients with low
back pain, consulting in primary care. The ÖMPSQ (21 items) has
been available for nearly a decade and is a popular clinical tool
with numerous external validation studies in comparison to the
STarT Back Tool (9-items), which has been more recently validated
and has potential advantages in terms of its length and scoring
simplicity. Both share broadly similar purposes, although subtle
conceptual differences have become apparent through conducting
this investigation, which should be highlighted for clinicians seek-
ing to choose which tool is most appropriate for their context.
Firstly, the ÖMPSQ was conceived as a prognostic screening tool,
although in practice it has adopted a subgrouping function with
established cut-offs across a variety of settings to allocate patients
to low and high risk groups. In contrast, the SBT was primarily con-
ceived as a subgrouping tool, with cut-offs based on baseline fac-
tors and not on future outcome, and for speciﬁcally deﬁned low,
medium and high risk treatment subgroups.oups derived using SBT and ÖMPSQ cut-offs.
Medium High
SBT ÖMPSQ SBT ÖMPSQ
45 [39–52] 48 [39–56] 49[39–54] 50 [37–54]
57 52 54 63
3 [2–5] 3 [2–4] 4 [4–5] 5 [3–5]
4 [3–4] 4 [3–4] 4 [4–5] 4 [3–5]
] 4.3 [3.0–5.7] 3.3 [3.0–5.3] 6.7 [4.8–8.2] 6.3 [4.9–7.7]
3 [1–4] 2 [1–4] 4 [2–4] 4 [3–4]
41 [37–44] 41 [40–44] 47 [43–52] 45 [42–51]
19 [11–23] 22 [14–27] 31 [21–38] 28 [20–38]
11 [6–13] 7 [5–13] 16 [13–19] 14 [11–17]
108 [90–127] 101 [94–105] 142 [124–175] 141 [126–158]
5 [4–6] 5 [3–6] 8 [7–8] 6 [6–8]
2 [2–3] 2 [2–3] 4 [4–5] 4 [3–4]
S, Numerical Rating Scale; PCS, Pain Catastrophising Scale; ÖMPSQ, Örebro Muscu-
hs to 3 years, 5 = >3 years.
= extremely.
= >3-months.
niﬁcant using the Mann Whitney test for continuous data and the Chi-squared test
iffered).
Fig. 2. Receiver operating characteristic (ROC) curves of ÖMPSQ and SBT scores against reference standards for (a) disability and pain, (b) catastrophising and fear, (c) referred
leg pain and bothersomeness, and (d) time off work and episode duration.
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This study found that the completion rate for both instruments
was high (n = 130/131 for both) and that their three subgroups’
clinical characteristics were broadly similar. Agreement over the
two instrument’s allocation to a ‘low’ risk subgroup was ‘substan-
tial’, suggesting that both tools have a similar ability to differenti-
ate patients based on their baseline characteristics. Although the
characteristics of patients in the three subgroups allocated by each
tool were not signiﬁcantly different, signiﬁcant differences were
observed in the proportions of patients allocated to the ‘high’and ‘medium’ risk groups, with a smaller proportion of patients
allocated to the high risk group by the SBT than the ÖMPSQ. One
factor in the choice of instrument used by clinicians may therefore
be the availability of services for the management of a high risk
group of patients.
An analysis of both instrument scales’ abilities to discriminate a
number of relevant reference standards was investigated to deter-
mine whether similarities in the subgroup clinical characteristics
were due to tool cut-off points used, or due to similar discrimi-
native abilities of the instrument scales. The results demon-
strated that the two instrument scales similarly discriminated
Table 3
AUCs (95% CIs) of SBT (total and subscale scores) and ÖMPSQ scores for discriminating ‘cases’ on reference standards.
Clinical characteristics deﬁned using ‘cases’ on reference standards AUCs (95% CIs) p Value
SBT total score SBT psychosocial subscale ÖMPSQ total score
Bothered by back painP ‘very’ .924 (.880, .968) .848 (.784, .913) 0.0045
Disability RMDQP 7 .937 (.896, .978) .934 (.892, .976) 0.9214
Catastrophising PCSP 20 .787 (.708, .867) .832 (.762, .901) .847 (.780, .915) 0.5597
Fear TSKP 41 .787 (.708, .866) .813 (.739, .887) .856 (.790, .921) 0.1443
Pain intensity NRSP 3.7 .825 (.754, .896) .891 (.836, .945) 0.0131
Referred leg pain ‘yes’ .841 (.774, .908) .769 (.685, .852) 0.0106
Comorbid painP 3 sites .683 (.586, .780) .686 (.589, .782) 0.9457
Time off workP 30 days .885 (.818, .952) .884 (.809, .960) 0.9857
Episode durationP 3-months .706 (.613, .799) .763 (.676, .850) 0.1062
RMDQ, Roland and Morris Disability Questionnaire; PCS, Pain Catastrophising Scale; TSK, Tampa Scale of Kinesiophobia; NRS, Numerical Response Scale; SBT, STarT Back Tool;
ÖMPSQ, Örebro Musculoskeletal Pain Screening Questionnaire.
To test for statistical differences between AUCs, the DeLong et al. (1988) algorithm for comparing AUCs was used.
88 J.C. Hill et al. / European Journal of Pain 14 (2010) 83–89the majority of clinical characteristics including disability, cata-
strophising, fear, comorbid pain, time off work or episode duration.
The ÖMPSQ total scale was signiﬁcantly better at discriminating
patients’ baseline pain intensity, while the SBT was better for dis-
criminating baseline bothersomeness of back pain and referred leg
pain.
4.2. Limitations
One substantial limitation of this study is that only cross-sec-
tional data was available for directly comparing the performance
of both instruments, preventing a comparison of the instrument’s
predictive validity. However, guidelines for the management of
non-speciﬁc back pain highlight the importance of identifying indi-
cators of poor prognosis, rather than predicting individual patient’s
outcomes, in order that treatment can be targeted appropriately
(Chou et al., 2007; van Tulder et al., 2006). Traditionally, validation
of the utility of such instrument scales has predominantly focused
on establishing an instrument’s predictive validity, although the
SBT subgroup cut-offs were speciﬁcally validated to optimally dif-
ferentiate patients with speciﬁc baseline clinical characteristics. To
date, there have been no studies that have compared the predictive
abilities of both instruments within a single sample, but published
data on the predictive validity of the ÖMPSQ (Hockings et al., 2008)
reports AUCs for persisting disability from 0.68 to 0.83, which com-
pares similarly to reported AUCs of 0.80 for the SBT (Hill PhD The-
sis, 2008). A further limitation is the potential for non-response
bias inﬂuencing generalizability as only 53% of the sample re-
sponded, which may have inﬂated the proportion classiﬁed by
the two instruments to the medium and high risk subgroups, as
people with longer term or more severe problems are more likely
to respond to the questionnaire. However, non-response bias is
likely to have equally affected both instruments and is unlikely
to have inﬂuenced the tool comparisons made in this study.
5. Conclusion
This study has compared measurement properties of the SBT to
those of the ÖMPSQ, and found them to be similar in respect to the
subgroup patient characteristics and abilities of the scales to differ-
entiate according to validated reference standard measures. The
SBT is quicker for patients to complete and easier for clinicians
to score, although is able to identify a high risk subgroup with sim-
ilar clinical characteristics to the ÖMPSQ. Apart from the differ-
ences in instrument length, the results of this study suggest that
the main difference between the two instruments was the propor-
tion of patients each tool allocated to the high risk group, with the
SBT identifying 25% as high risk, and the ÖMPSQ 38% as high risk.
This might be of relevance to clinicians working within servicesthat have resource limitations for treating high risk patients. Rec-
ommendations for future research include; a direct comparison
of the predictive validity of both instruments, and also an investi-
gation of possible instrument item redundancy. Clinicians need to
be aware of the relative strengths and weakness of the two clinical
tools before selecting which tool is most appropriate to help deci-
sion making in their speciﬁc clinical context and setting. This head
to head comparison has demonstrated that the SBT’s discrimina-
tive abilities appear to be at least equivalent, and preferable in
some criteria, to the ÖMPSQ, which is the most widely used current
tool in clinical practice.
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